GVK Biosciences (GVK BIO), Asia’s leading drug discovery research & development organization, announced today that AstellasPharma Inc. (Tokyo:4503, “Astellas”) extended and renewed its license to the GVK BIO SAR Databases (GOSTAR).
SHL recently had the opportunity to participate, along with various other experts in the industry, in a questionnaire held by PharmTech.com on the topic of 'Pointed Debate: Expert Views on Injectables.' The article features each participant's respective insights on the injectable industry, more specifically in the area of self-administration and related technologies.
We have received a new GMP certificate, issued by the Swedish Medial Product Agency (MPA), based on an on-site inspection performed during December, 2011.
Signalling a further commitment to expand its business model in the Pacific Rim, and building a global presence as one of the largest imaging and cardiac safety core labs in the world, CoreLab Partners today has announced the opening of an office in Tokyo, Japan, under the wholly owned subsidiary of CoreLab Partners Japan, K.K.
SHL has launched a white paper on the topic of 'Auto Injectors: From Planning to Launch' with the goal of sharing with readers insights on how to prepare for the overall development process from different perspectives including design, regulatory and manufacturing. This press release gives an overview of the paper.
SHL was recently featured in an article published by BioSpectrum Asia on the topic of "The Emerging Drug Delivery Landscape." In the article, SHL is identified as an innovator of auto injectors in Asia and continues to respond to increasing demands by expanding the pipeline of devices and investing more in design expertise and R&D.
Most people are aware of the essential role Vitamin D plays in maintaining strong bones and muscles however many people are shocked to learn of the link between Vitamin D deficiency and serious health conditions such as cancer, diabetes, auto-immune disorders and cardiovascular disease. In light of this and recent research indicating approximately half of the world’s population are Vitamin D deficient it’s not surprising the demand for Vitamin D testing is so high.
The liquid ready to use Cystatin C assay from Randox provides a good indicator of Glomerular Filtration Rate (GRF). As a more sensitive maker of renal dysfunction, Cystatin C offers several advantages over traditional creatinine assays.
Euroscreen SA commented today on their recent, joint Nature publication with Novartis revealing the discovery of a novel therapeutic target for the treatment of immune disorders.
Haupt Pharma invests in modern tablet compression technology for the efficient production of solid dosage forms with adhesive tendencies.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.